Skip to main content

APLS Competitors

profileAnalyst coverage5 yr. financialspremium researchdividendsadv. chartsearningsoptionsprice historyeventsinsiders

Apellis Pharmaceuticals Inc. News

Cramer's Mad Money Recap 10/6: Dow, General Motors

Jim Cramer says it's hard to explain why stocks opened lower, but he thinks investors should have some conviction and look for buying opportunities.

5 Top Stock Gainers for Monday: Discovery, Apellis Pharma

Apellis Pharmaceuticals, Harley-Davidson, Dillard's, Children's Place and Harmony Gold are five top gainers for Monday.

Apellis Jumps on Blood Disease Treatment Approval

Apellis says the U.S. Food & Drug Administration has approved its Empaveli treatment for a rare blood disease.

Editas Medicine Falls as Goldman Sachs Initiates the Stock at Sell

Editas is initiated with a sell rating and $20 price target at Goldman Sachs.

Resilient Bull: Cramer's 'Mad Money' Recap (Wednesday 1/8/20)

Jim Cramer says this market environment is a strange merger of resilience, complacency and hubris. He explains how this feeds a stock rally.

Breaking News

Costco May Have a Huge Workers Problem

Workers demand for their needs to be met.

Real Estate Titan Zillow Sees Tough Times Ahead in Housing

The residential real estate market has stumbled, after soaring in the first 18 months of the covid pandemic.

Meta (Facebook) Looks to Take on TikTok Next

Facebook and Instagram's parent company has a plan to take over a new segment.